These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26655499)

  • 1. Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axis.
    Kato H; Naiki-Ito A; Naiki T; Suzuki S; Yamashita Y; Sato S; Sagawa H; Kato A; Kuno T; Takahashi S
    Oncotarget; 2016 Jan; 7(2):2009-21. PubMed ID: 26655499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.
    Sagawa H; Naiki-Ito A; Kato H; Naiki T; Yamashita Y; Suzuki S; Sato S; Shiomi K; Kato A; Kuno T; Matsuo Y; Kimura M; Takeyama H; Takahashi S
    Carcinogenesis; 2015 Dec; 36(12):1539-49. PubMed ID: 26494227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
    Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
    J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
    Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver.
    Neveu MJ; Hully JR; Babcock KL; Hertzberg EL; Nicholson BJ; Paul DL; Pitot HC
    J Cell Sci; 1994 Jan; 107 ( Pt 1)():83-95. PubMed ID: 8175925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent carcinogenic susceptibility in rat liver is related to potential of gap junctional intercellular communication.
    Naiki-Ito A; Kato H; Asamoto M; Naiki T; Shirai T
    Toxicol Pathol; 2012 Jul; 40(5):715-21. PubMed ID: 22569583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.
    Wei X; Tang C; Lu X; Liu R; Zhou M; He D; Zheng D; Sun C; Wu Z
    Oncotarget; 2015 Jul; 6(21):18389-405. PubMed ID: 26158762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat.
    Hokaiwado N; Asamoto M; Ogawa K; Shirai T
    Toxicol Pathol; 2005; 33(6):695-701. PubMed ID: 16243774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation.
    Neveu MJ; Hully JR; Paul DL; Pitot HC
    Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of low-density lipoprotein receptor class A domain-containing protein 4 (Ldlrad4) in the liver of rats treated with nongenotoxic hepatocarcinogen to induce transforming growth factor β signaling promoting cell proliferation and suppressing apoptosis in early hepatocarcinogenesis.
    Ito Y; Nakajima K; Masubuchi Y; Kikuchi S; Okano H; Saito F; Akahori Y; Jin M; Yoshida T; Shibutani M
    J Appl Toxicol; 2020 Nov; 40(11):1467-1479. PubMed ID: 32596862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
    Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
    Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis.
    Yachida S; Imaida K; Yokohira M; Hashimoto N; Suzuki S; Okano K; Wakabayashi H; Maeta H; Suzuki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3386-93. PubMed ID: 20589433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
    Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
    Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of Bcl-x protein during hepatocarcinogenesis induced exogenously and endogenously in rats.
    Hatanaka Y; Nakae D; Mutai M; Hashizume K; Kamihara Y; Kinoshita N; Tani Y; Danno Gi G; Ohta S; Konishi Y; Ashida H
    Jpn J Cancer Res; 2001 Dec; 92(12):1270-7. PubMed ID: 11749691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
    Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
    Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.
    Hokaiwado N; Asamoto M; Futakuchi M; Ogawa K; Takahashi S; Shirai T
    J Membr Biol; 2007 Aug; 218(1-3):101-6. PubMed ID: 17978847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.